Der er rapporteret om øget risiko for udvikling af lymfoproliferative lidelser hos EBV - Viral Capsid Antigen (VCA) - negative patienter.
EBV-Viral Capsid Antigen (VCA)-negative patients have been reported to have an increased risk of developing lymphoproliferative disorders.